Crocs, Inc. (NASDAQ:CROX – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $122.50 and last traded at $124.1790, with a volume of 23829 shares traded. The stock had previously closed at $119.35.
Analyst Ratings Changes
A number of equities research analysts have recently commented on CROX shares. Barclays increased their price target on shares of Crocs from $109.00 to $110.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. Needham & Company LLC lifted their target price on Crocs from $118.00 to $132.00 and gave the stock a “buy” rating in a report on Tuesday, April 21st. UBS Group upped their price target on Crocs from $97.00 to $107.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Piper Sandler reaffirmed a “neutral” rating and set a $95.00 price objective on shares of Crocs in a research report on Thursday, February 12th. Finally, Robert W. Baird set a $150.00 price objective on Crocs and gave the stock an “outperform” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, Crocs currently has an average rating of “Hold” and a consensus target price of $111.64.
Read Our Latest Analysis on Crocs
Crocs Trading Up 1.6%
Crocs (NASDAQ:CROX – Get Free Report) last posted its earnings results on Thursday, April 30th. The textile maker reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.78 by $0.21. Crocs had a negative net margin of 2.58% and a positive return on equity of 48.29%. The firm had revenue of $921.46 million for the quarter, compared to the consensus estimate of $900.57 million. During the same period in the previous year, the firm posted $3.00 EPS. The business’s quarterly revenue was down 1.7% on a year-over-year basis. Crocs has set its Q2 2026 guidance at 4.150-4.350 EPS and its FY 2026 guidance at 13.200-13.750 EPS. On average, equities research analysts expect that Crocs, Inc. will post 13.67 EPS for the current fiscal year.
Institutional Trading of Crocs
Institutional investors have recently added to or reduced their stakes in the company. Root Financial Partners LLC lifted its position in shares of Crocs by 96.3% during the first quarter. Root Financial Partners LLC now owns 320 shares of the textile maker’s stock worth $27,000 after purchasing an additional 157 shares during the last quarter. Torren Management LLC acquired a new stake in Crocs in the fourth quarter valued at approximately $39,000. Parallel Advisors LLC boosted its position in shares of Crocs by 60.2% in the 3rd quarter. Parallel Advisors LLC now owns 495 shares of the textile maker’s stock worth $41,000 after purchasing an additional 186 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in shares of Crocs during the third quarter valued at about $48,000. Finally, IMA Advisory Services Inc. boosted its stake in Crocs by 72.7% in the 3rd quarter. IMA Advisory Services Inc. now owns 646 shares of the textile maker’s stock worth $54,000 after purchasing an additional 272 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.
Crocs Company Profile
Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.
Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.
Recommended Stories
- Five stocks we like better than Crocs
- Planet Labs: Coming Back Down to Earth
- Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong
- Meta Unveils Subscriptions: A New Offering With Real Growth Potential
- 3 Longevity ETFs to Buy and Hold (and Hold)
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.
